This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
PATHOGENIC ROLE OF AUTOFAGIC / LYSOSOMAL DYSFUNCTION IN PARKINSON DISEASE: DIAGNOSIS AND NEW PRE-CLINICAL THERAPIES Investments < €500k Spain 2016
STUDY OF THE ROLE OF THE ALPHA-KLOTHO SOLUBLE ISOFORM IN THE START AND PROGRESSION OF COGNITIVE DEFICITS: PRECIOUS DIAGNOSTIC MARKER, AND DIANA MOLECULA WITH THERAPEUTIC POTENTIAL Investments < €500k Spain 2016
CLINICAL-GENETIC CORRELATIONS IN DEMENTIA AND FAMILY PRESERVED nonagenarian cognitively Investments < €500k Spain 2016
DEVELOPMENT OF A NEW MODEL OF PARKINSON DISEASE BY nonhuman primates PLK2 overexpression of dopaminergic neurons Investments < €500k Spain 2016
EVALUATION OF THE IMPACT OF IMAGE PET amyloid-BETA IN THE DIAGNOSIS AND CONTROL CLINIC OF patients with cognitive impairment EVALUATED BY SUSPECTED Alzheimer’s disease (AD). Investments < €500k Spain 2016
PHENOTYPES AND HAPLOTIPOSES ASSOCIATED WITH INTERTURED GENEAL ALTERS, HUNTINGTON DISEASE Investments < €500k Spain 2016
PARKINSON DISEASE MODEL WITH INDUCID PLURIPOTENT CELLS BEARING THE E46K MUTATION IN ALPHA-SINUCLEINE, TO IDENTIFY PATHOGENIC ROUTES Investments < €500k Spain 2016
GENERAL VARIABLES ASSOCIATED RISK AND MORTALITY AFTER diagnosis of dementia in general population Investments < €500k Spain 2016
PROGRAM OF PHYSICAL ACTIVITY FOR PATIENTS WITH DEMENTIA AND THEIR FAMILY CAREGIVERS. RANDOM CLINICAL TEST IN PRIMARY CARE Investments < €500k Spain 2016
MOLECULAR MODULATION OF EXTRASINAPTIC COMPLEXES OF NMDA RECEPTORS AS A THERAPEUTIC STRATEGY FOR ALZHEIMER’S DISEASE Investments < €500k Spain 2016
